Thanks to Harris for supporting market foolery.

Harris stands behind the quality of their blades,

but they know that switching raisers isn't an easy decision.

So they created a trial offer.

Claim yours by going to Harry's dot com slash fool.

It's Tuesday, July 17th.

Welcome to Market Foolery.

I'm Matt Greer and joining me in studio,

we have Motley Full analyst Andy Cross and Jason

Moser guys welcome hey how you doing how you feeling good feeling great good

good well I am too and on today's show we're going to talk some health care as in United

Health we're going to talk some Johnson and Johnson. Turns out guys not just

baby powder.

Pharma. Having some talc problems. Yeah well tal, talc, we'll get to that. I do find that my daughter really enjoys the baby oil in her slime production just for any of you parents out there who have kids getting into the slime game,

apparently Johnson's and Johnson.

I just used like the old-fashioned Johnson and Johnson's shampoo for the first time in years.

Already, already delivering value and we haven't even gotten to our first stock.

It was a little bottle right there, it's great.

Okay guys, but let's kick things off with Netflix earnings.

Now we've got some concerns over slowing subscriber growth and Jason shares down around 8% at the time of our taping, but that wasn't near as bad as they had been at the open of the market. Now I got to ask you here. Netflix

the stock has been on an incredible role. Their earnings were actually better

than expected. So is this a case of just unrealistic or unsustainable expectations or is there

...